You're reading: The Economist: Pfizer’s and BioNTech’s vaccine is the start of the end of the pandemic

The Economist: Pfizer’s and BioNTech’s vaccine is the start of the end of the pandemic

Published Nov. 10, 2020 at 1:59 am

NEW YORK, NY - NOVEMBER 09: People walk by the Pfizer headquarters on November 9, 2020 in New York City. Pharmaceutical company Pfizer announced positive early results on its COVID-19 vaccine trial and has proven to be 90% effective in preventing infection of the virus. David Dee Delgado/Getty Images/AFP

Photo by AFP

During this coronavirus-blighted year, through many difficult days of isolation and fear, the world has hoped for better times. It has hoped for better treatments for covid-19, faster testing and better understanding of how SARS-CoV-2 wreaks havoc on the human body.